Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

378 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Novel therapeutic strategies in prostate cancer.
Retter AS, Gulley JL, Dahut WL. Retter AS, et al. Among authors: gulley jl. Cancer Biol Ther. 2004 Apr;3(4):371-6. doi: 10.4161/cbt.3.4.725. Epub 2004 Apr 29. Cancer Biol Ther. 2004. PMID: 14726702 Review.
Higher incidence of Osteonecrosis of the Jaw (ONJ) in patients with metastatic castration resistant prostate cancer treated with anti-angiogenic agents.
Aragon-Ching JB, Ning YM, Chen CC, Latham L, Guadagnini JP, Gulley JL, Arlen PM, Wright JJ, Parnes H, Figg WD, Dahut WL. Aragon-Ching JB, et al. Among authors: gulley jl. Cancer Invest. 2009 Feb;27(2):221-6. doi: 10.1080/07357900802208608. Cancer Invest. 2009. PMID: 19235596 Free PMC article. Clinical Trial.
Prostvac-VF: a vector-based vaccine targeting PSA in prostate cancer.
Madan RA, Arlen PM, Mohebtash M, Hodge JW, Gulley JL. Madan RA, et al. Among authors: gulley jl. Expert Opin Investig Drugs. 2009 Jul;18(7):1001-11. doi: 10.1517/13543780902997928. Expert Opin Investig Drugs. 2009. PMID: 19548854 Free PMC article. Review.
Immunologic and prognostic factors associated with overall survival employing a poxviral-based PSA vaccine in metastatic castrate-resistant prostate cancer.
Gulley JL, Arlen PM, Madan RA, Tsang KY, Pazdur MP, Skarupa L, Jones JL, Poole DJ, Higgins JP, Hodge JW, Cereda V, Vergati M, Steinberg SM, Halabi S, Jones E, Chen C, Parnes H, Wright JJ, Dahut WL, Schlom J. Gulley JL, et al. Cancer Immunol Immunother. 2010 May;59(5):663-74. doi: 10.1007/s00262-009-0782-8. Epub 2009 Nov 5. Cancer Immunol Immunother. 2010. PMID: 19890632 Free PMC article. Clinical Trial.
Clinical evaluation of TRICOM vector therapeutic cancer vaccines.
Madan RA, Bilusic M, Heery C, Schlom J, Gulley JL. Madan RA, et al. Among authors: gulley jl. Semin Oncol. 2012 Jun;39(3):296-304. doi: 10.1053/j.seminoncol.2012.02.010. Semin Oncol. 2012. PMID: 22595052 Free PMC article. Review.
378 results